Published in Cancer Weekly, September 20th, 2005
"Previous microarray studies on breast cancer identified multiple tumor classes, of which the most prominent, named luminal and basal, differ in expression of the estrogen receptor alpha gene (ER)," scientists in Switzerland explained.
In a recent study, P. Farmer and coauthors at the Swiss Institute of Bioinformatics identified "a group of breast tumors with increased androgen signalling and a 'molecular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.